scholarly journals Cancer Cell–Membrane Biomimetic Boron Nitride Nanospheres for Targeted Cancer Therapy

2021 ◽  
Vol Volume 16 ◽  
pp. 2123-2136
Author(s):  
Shini Feng ◽  
Yajing Ren ◽  
Hui Li ◽  
Yunfei Tang ◽  
Jinyu Yan ◽  
...  
Small ◽  
2021 ◽  
pp. 2006484
Author(s):  
Fatemeh Oroojalian ◽  
Mohammad Beygi ◽  
Behzad Baradaran ◽  
Ahad Mokhtarzadeh ◽  
Mohammad‐Ali Shahbazi

ACS Nano ◽  
2019 ◽  
Vol 13 (3) ◽  
pp. 2849-2857 ◽  
Author(s):  
Wei Xie ◽  
Wei-Wei Deng ◽  
Minghui Zan ◽  
Lang Rao ◽  
Guang-Tao Yu ◽  
...  

ChemNanoMat ◽  
2020 ◽  
Vol 6 (12) ◽  
pp. 1712-1729
Author(s):  
Chethana Rao ◽  
Pushpendra Mani Mishra ◽  
Aditya Yadav ◽  
Chayan Kanti Nandi

2019 ◽  
Vol 14 (1) ◽  
Author(s):  
Jinyuan He ◽  
Chulian Gong ◽  
Jie Qin ◽  
Mingan Li ◽  
Shaohong Huang

Abstract Current cancer therapy usually succumbs to many extracellular and intracellular barriers, among which untargeted distribution and multidrug resistance (MDR) are two important difficulties responsible for poor outcome of many drug delivery systems (DDS). Here, in our study, the dilemma was addressed by developing a cancer cell membrane (CCM)-coated silica (SLI) nanoparticles to co-deliver miR495 with doxorubicin (DOX) for effective therapy of lung cancer (CCM/SLI/R-D). The homologous CCM from MDR lung cancer cells (A549/DOX) was supposed to increase the tumor-homing property of the DDS to bypass the extracellular barriers. Moreover, the MDR of cancer cells were conquered through downregulation of P-glycoprotein (P-gp) expression using miR495. It was proved that miR495 could significantly decrease the expression of P-gp which elevated intracellular drug accumulation in A549/DOX. The in vitro and in vivo results exhibited that CCM/SLI/R-D showed a greatly enhanced therapeutic effect on A549/DOX, which was superior than applying miR495 or DOX alone. The preferable effect of CCM/SLI/R-D on conquering the MDR in lung cancer provides a novel alternative for effective chemotherapy of MDR cancers.


Small ◽  
2020 ◽  
Vol 16 (39) ◽  
pp. 2070215
Author(s):  
Mengyun Zhou ◽  
Yi Xing ◽  
Xiaoyu Li ◽  
Xin Du ◽  
Tailin Xu ◽  
...  

2020 ◽  
Vol 117 (36) ◽  
pp. 22390-22401 ◽  
Author(s):  
Shuo Shi ◽  
Zhen-Zhen Yang ◽  
Sanhong Liu ◽  
Fan Yang ◽  
Haifan Lin

Targeted cancer therapy aims to achieve specific elimination of cancerous but not normal cells. Recently, PIWI proteins, a subfamily of the PAZ-PIWI domain (PPD) protein family, have emerged as promising candidates for targeted cancer therapy. PPD proteins are essential for small noncoding RNA pathways. The Argonaute subfamily partners with microRNA and small interfering RNA, whereas the PIWI subfamily partners with PIWI-interacting RNA (piRNA). Both PIWI proteins and piRNA are mostly expressed in the germline and best known for their function in transposon silencing, with no detectable function in mammalian somatic tissues. However, PIWI proteins become aberrantly expressed in multiple types of somatic cancers, thus gaining interest in targeted therapy. Despite this, little is known about the regulatory mechanism of PIWI proteins in cancer. Here we report that one of the four PIWI proteins in humans, PIWIL1, is highly expressed in gastric cancer tissues and cell lines. Knocking out the PIWIL1 gene (PIWIL1-KO) drastically reduces gastric cancer cell proliferation, migration, metastasis, and tumorigenesis. RNA deep sequencing of gastric cancer cell line SNU-1 reveals that KO significantly changes the transcriptome, causing the up-regulation of most of its associated transcripts. Surprisingly, few bona fide piRNAs exist in gastric cancer cells. Furthermore, abolishing the piRNA-binding activity of PIWIL1 does not affect its oncogenic function. Thus, PIWIL1 function in gastric cancer cells is independent of piRNA. This piRNA-independent regulation involves interaction with the UPF1-mediated nonsense-mediated mRNA decay (NMD) mechanism. Altogether, our findings reveal a piRNA-independent function of PIWIL1 in promoting gastric cancer.


2014 ◽  
Vol 6 (4) ◽  
pp. e95-e95 ◽  
Author(s):  
Qiaoling Liu ◽  
Chen Jin ◽  
Yanyue Wang ◽  
Xiaohong Fang ◽  
Xiaobing Zhang ◽  
...  

Nano Research ◽  
2022 ◽  
Author(s):  
Fudan Dong ◽  
Qikun Jiang ◽  
Lingxiao Li ◽  
Tian Liu ◽  
Shiyi Zuo ◽  
...  

Nanoscale ◽  
2016 ◽  
Vol 8 (13) ◽  
pp. 6981-6985 ◽  
Author(s):  
S. Krishnamurthy ◽  
M. K. Gnanasammandhan ◽  
C. Xie ◽  
K. Huang ◽  
M. Y. Cui ◽  
...  

Core–shell type ‘nanoghosts’ were synthesized with a biodegradable PLGA core and a monocyte cell membrane-derived shell. The ∼200 nm doxorubicin-loaded nanoghosts showed greater cellular uptake and cytotoxicity compared to non-coated nanoparticle controls in metastatic MCF-7 breast cancer cell lines.


Sign in / Sign up

Export Citation Format

Share Document